|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9601
|
|
pubmed:dateCreated |
2007-11-26
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
We aimed to assess the efficacy of the oral live attenuated human rotavirus vaccine Rotarix (RIX4414) for prevention of rotavirus gastroenteritis in European infants during their first 2 years of life.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1474-547X
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
24
|
|
pubmed:volume |
370
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1757-63
|
|
pubmed:dateRevised |
2010-10-6
|
|
pubmed:meshHeading |
pubmed-meshheading:18037080-Double-Blind Method,
pubmed-meshheading:18037080-Europe,
pubmed-meshheading:18037080-Feces,
pubmed-meshheading:18037080-Female,
pubmed-meshheading:18037080-Gastroenteritis,
pubmed-meshheading:18037080-Humans,
pubmed-meshheading:18037080-Infant,
pubmed-meshheading:18037080-Male,
pubmed-meshheading:18037080-Rotavirus,
pubmed-meshheading:18037080-Rotavirus Infections,
pubmed-meshheading:18037080-Rotavirus Vaccines,
pubmed-meshheading:18037080-Severity of Illness Index,
pubmed-meshheading:18037080-Vaccines, Attenuated
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study.
|
|
pubmed:affiliation |
Vaccine Research Centre, Medical School, University of Tampere, Tampere, Finland. timo.vesikari@uta.fi
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Multicenter Study
|
